Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice (Q48362489)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 October 2012

Language	Label	Description	Also known as
English	Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice	scientific article published on 25 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

object named as

Annie Andrieux

5

0 references

author name string

Vincent Fournet

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Gaetan de Lavilléon

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Annie Schweitzer

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Marie-Pascale Martres

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

language of work or name

0 references

publication date

25 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

number of pages

15

1 reference

based on heuristic

inferred from page(s)

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

123

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

982-996

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Cognitive deficits in depression: possible implications for functional neuropathology

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Post-pubertal emergence of alterations in locomotor activity in stop null mice.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Schizophrenia genetics: dysbindin under the microscope

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Current advances and trends in the treatment of depression

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Dopaminergic transmission in STOP null mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The DISC locus in psychiatric illness

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Dysbindin (DTNBP1)--a role in psychotic depression?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The burden of mental disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The synaptic hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The microtubule cytoskeleton acts as a key downstream effector of neurotransmitter signaling

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Fluoxetine's effects on cognitive performance in patients with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Association of DISC1 with autism and Asperger syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Common risk genes for affective and schizophrenic psychoses

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Mood disorders and allostatic load

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Disruption of two novel genes by a translocation co-segregating with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Therapeutic potential of fluoxetine in neurological disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

An update on the genetics of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Schizophrenia: genes at last?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Neurocognitive impairment in drug-free patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Cognitive impairments in the STOP null mouse model of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Psychosis pathways converge via D2high dopamine receptors

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Evidence for continuing neuropsychological impairments in depression.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Identifiers

10.1111/JNC.12027

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48362489&oldid=2195866106"